iifl-logo

Glaxosmithkline Pharmaceuticals Ltd Dividend

3,438.5
(-0.80%)
Jun 6, 2025|12:00:00 AM

Glaxosmi. Pharma CORPORATE ACTIONS

10/06/2024calendar-icon
10/06/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend13 May 202530 May 202530 May 202542420Final
The Board has recommended a final dividend of Rs.42/- per equity share on face value of Rs .10 each for the year ended 31 st March 2025, subject to approval of members at 100th Annual General Meeting
Dividend29 Oct 20247 Nov 20247 Nov 202412120Special
Outcome of Meeting The Board has recommended Special Interim dividend of Rs. 12/- (120%) per equity share on face value of Rs.10 each of the Company.

Glaxosmi. Pharma: Related News

Top 10 stocks for today – 4th September 2024
4 Sep 2024|09:16 AM

Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.